268 related articles for article (PubMed ID: 21956898)
1. Brief report: phenotypic rescue of induced pluripotent stem cell-derived motoneurons of a spinal muscular atrophy patient.
Chang T; Zheng W; Tsark W; Bates S; Huang H; Lin RJ; Yee JK
Stem Cells; 2011 Dec; 29(12):2090-3. PubMed ID: 21956898
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of proximal autosomal recessive spinal muscular atrophy.
Simic G
Acta Neuropathol; 2008 Sep; 116(3):223-34. PubMed ID: 18629520
[TBL] [Abstract][Full Text] [Related]
3. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
[TBL] [Abstract][Full Text] [Related]
4. A new model to study spinal muscular atrophy: neurite degeneration and cell death is counteracted by BCL-X(L) Overexpression in motoneurons.
Garcera A; Mincheva S; Gou-Fabregas M; Caraballo-Miralles V; Lladó J; Comella JX; Soler RM
Neurobiol Dis; 2011 Jun; 42(3):415-26. PubMed ID: 21333739
[TBL] [Abstract][Full Text] [Related]
5. Death of motoneurons induced by trophic deprivation or by excitotoxicity is not prevented by overexpression of SMN.
Cisterni C; Kallenbach S; Jordier F; Bagnis C; Pettmann B
Neurobiol Dis; 2001 Apr; 8(2):240-51. PubMed ID: 11300720
[TBL] [Abstract][Full Text] [Related]
6. Modeling the differential phenotypes of spinal muscular atrophy with high-yield generation of motor neurons from human induced pluripotent stem cells.
Lin X; Li JJ; Qian WJ; Zhang QJ; Wang ZF; Lu YQ; Dong EL; He J; Wang N; Ma LX; Chen WJ
Oncotarget; 2017 Jun; 8(26):42030-42042. PubMed ID: 28159932
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib increases SMN and survival in a severe spinal muscular atrophy mouse model via p38 pathway activation.
Farooq F; Abadía-Molina F; MacKenzie D; Hadwen J; Shamim F; O'Reilly S; Holcik M; MacKenzie A
Hum Mol Genet; 2013 Sep; 22(17):3415-24. PubMed ID: 23656793
[TBL] [Abstract][Full Text] [Related]
9. An essential SMN interacting protein (SIP1) is not involved in the phenotypic variability of spinal muscular atrophy (SMA).
Helmken C; Wetter A; Rudnik-Schöneborn S; Liehr T; Zerres K; Wirth B
Eur J Hum Genet; 2000 Jul; 8(7):493-9. PubMed ID: 10909848
[TBL] [Abstract][Full Text] [Related]
10. Neurodevelopmental abnormalities in neurosphere-derived neural stem cells from SMN-depleted mice.
Shafey D; MacKenzie AE; Kothary R
J Neurosci Res; 2008 Oct; 86(13):2839-47. PubMed ID: 18521935
[TBL] [Abstract][Full Text] [Related]
11. The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin.
Nölle A; Zeug A; van Bergeijk J; Tönges L; Gerhard R; Brinkmann H; Al Rayes S; Hensel N; Schill Y; Apkhazava D; Jablonka S; O'mer J; Srivastav RK; Baasner A; Lingor P; Wirth B; Ponimaskin E; Niedenthal R; Grothe C; Claus P
Hum Mol Genet; 2011 Dec; 20(24):4865-78. PubMed ID: 21920940
[TBL] [Abstract][Full Text] [Related]
12. Stem cell-derived neurotrophic support for the neuromuscular junction in spinal muscular atrophy.
Wyatt TJ; Keirstead HS
Expert Opin Biol Ther; 2010 Nov; 10(11):1587-94. PubMed ID: 20955113
[TBL] [Abstract][Full Text] [Related]
13. Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCs.
Yoshida M; Kitaoka S; Egawa N; Yamane M; Ikeda R; Tsukita K; Amano N; Watanabe A; Morimoto M; Takahashi J; Hosoi H; Nakahata T; Inoue H; Saito MK
Stem Cell Reports; 2015 Apr; 4(4):561-8. PubMed ID: 25801509
[TBL] [Abstract][Full Text] [Related]
14. Smn deficiency causes neuritogenesis and neurogenesis defects in the retinal neurons of a mouse model of spinal muscular atrophy.
Liu H; Beauvais A; Baker AN; Tsilfidis C; Kothary R
Dev Neurobiol; 2011 Feb; 71(2):153-69. PubMed ID: 20862739
[TBL] [Abstract][Full Text] [Related]
15. Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy.
Xu CC; Denton KR; Wang ZB; Zhang X; Li XJ
Dis Model Mech; 2016 Jan; 9(1):39-49. PubMed ID: 26586529
[TBL] [Abstract][Full Text] [Related]
16. Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons.
Rossoll W; Jablonka S; Andreassi C; Kröning AK; Karle K; Monani UR; Sendtner M
J Cell Biol; 2003 Nov; 163(4):801-12. PubMed ID: 14623865
[TBL] [Abstract][Full Text] [Related]
17. Decay in survival motor neuron and plastin 3 levels during differentiation of iPSC-derived human motor neurons.
Boza-Morán MG; Martínez-Hernández R; Bernal S; Wanisch K; Also-Rallo E; Le Heron A; Alías L; Denis C; Girard M; Yee JK; Tizzano EF; Yáñez-Muñoz RJ
Sci Rep; 2015 Jun; 5():11696. PubMed ID: 26114395
[TBL] [Abstract][Full Text] [Related]
18. HuD and the Survival Motor Neuron Protein Interact in Motoneurons and Are Essential for Motoneuron Development, Function, and mRNA Regulation.
Hao le T; Duy PQ; An M; Talbot J; Iyer CC; Wolman M; Beattie CE
J Neurosci; 2017 Nov; 37(48):11559-11571. PubMed ID: 29061699
[TBL] [Abstract][Full Text] [Related]
19. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
[TBL] [Abstract][Full Text] [Related]
20. SMN deficiency attenuates migration of U87MG astroglioma cells through the activation of RhoA.
Caraballo-Miralles V; Cardona-Rossinyol A; Garcera A; Villalonga P; Soler RM; Olmos G; Lladó J
Mol Cell Neurosci; 2012 Mar; 49(3):282-9. PubMed ID: 22197680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
